# ASCORBIC ACID
> **ANDA220172** · Abbreviated New Drug Application (Generic) · Sponsor: STIRA · Approved 2026-07-30
## Drug
- **FDA Application Number:** ANDA220172
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ASCORBIC ACID
- **Generic name:** ASCORBIC ACID
- **Active ingredients:** ASCORBIC ACID
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** STIRA
- **Manufacturer:** Renova Pharmaceuticals LLC
- **First approval:** 2026-07-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220172)
---
*MORVS · CC0 1.0*